Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/4/09 → 3/31/11 |
Funding
- Eli Lilly and Company: $123,371.00
A Double Blind Study Placebo Controlled Studyof Atomoxetine Hydrochloride for the Treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents with ADHD and Comorbid Dyslexia
- Glaser, Paul (PI)
- Dennis, Mareen (CoI)
- Frueh, Kelli (CoI)
- Turpin, Sharon (CoI)